Stocknear Logo Stocknear
/
Popular
Login

Inhibikase Therapeutics I...

1.90
-0.08 (-4.04%)
At close: Apr 17, 2025, 3:59 PM

Inhibikase Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
n/a 260.5K 123.44K 3.1M 698.47K 1.12M 4.04M 2.06M 967.39K
n/a 13.62M 6.72K 11.36M 893.8K 2.55M 3.65M 1.76M 846.39K
n/a -13.36M 116.72K -8.26M -195.33K -1.43M 393.85K 305.25K 121K
-28.59M -20.09M -18.13M -14.77M -2.82M -5.7M -2.12M -405.13K -613.29K
1.07M 1.06M 74.45K 19.92K 29.4K 24.84K n/a 30.95K 15.45K
-27.52M -19.03M -18.05M -14.79M -2.85M -5.72M -2.15M -436.07K -628.74K
-27.52M -19.03M -17.91M -14.81M -2.88M -5.75M -2.15M -436.07K -628.74K
11.38M 6.73M 6.22M 6.51M 2.62M 4.27M 2.52M 710.38K 734.29K
17.21M 13.62M 12.03M 11.36M 893.8K 2.55M 3.65M 1.76M 846.39K
n/a -13.62M -123.44K -3.1M -698.47K -1.12M n/a n/a n/a
28.59M 6.73M 18.13M 14.77M 2.82M 5.7M 2.12M 2.47M 734.29K
n/a n/a 74.45K 19.92K 29.4K 24.84K 30.33K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
28.59M 20.35M 18.13M 14.77M 2.82M 5.7M 2.12M 2.47M 1.58M
n/a n/a -148.91K 19.92K 29.4K 24.84K -161.14K -405.13K -15.45K
23.71M 5.33M 4.2M 3.03M 1.68M 1.72M 1.34M 1.72M 1.3M
23.71M 5.33M 4.2M 3.03M 1.68M 1.72M 1.34M 1.72M 1.3M
-1.16 -3.57 -4.26 -4.88 -1.72 -3.34 -1.61 -0.25 -0.48
-1.16 -3.57 -4.26 -4.88 -1.72 -3.34 -1.61 -0.25 -0.48
-28.59M -19.91M -18.12M -14.77M -2.82M -5.7M n/a n/a n/a
n/a -20.09M -18.13M -14.77M -2.82M -5.7M -2.12M -405.13K -613.29K
n/a 177.4K 6.72K 14.77M 2.82M 5.7M 2.12M 405.13K 613.29K

Create Price Alert on IKT

Your price alert will notify you when the stock price is above 1.9.

Add to Watchlist